BRIEF-Dimension announces interim topline results from ongoing phase 1/2 clinical program for DTX101

* Dimension announces interim topline results from ongoing phase 1/2 clinical program for DTX101 Source text for Eikon: Further company coverage: [Source]

Publication Date: Tuesday, 31 January 2017 at 15:18:09

Origin: reuters.com

Category: rbssHealthcareNews

Topics: program, clinical, results, topline, interim, announces, coverage, company, Further, Eikon, DTX101 Source, ongoing phase, Dimension, DTX101, phase, ongoing, BRIEF-Dimension

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/44LGuGt7R_4/idUSFWN1FL0LS

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22

Analyzed News